Scholars Central

Short communicationPublished 13 Jul 2021

SARS-CoV-2: Genome, New Variant and Risk of Infection in Immunized Individuals

Authors: Edy Parwanto

Virology & Mycology

Volume 10 · Issue 3 · Pages 1–2

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The COVID-19 outbreak was caused by SARS-CoV-2. This situation is concerning because it has created uncertainty and has become a world problem. Regarding the COVID-19 outbreak, a genomic analysis of SARS-CoV-2 has been carried out. The genome of SARS-CoV-2 contains 29.903 nucleotides (nt). The SARS-CoV-2 genome consists of the: 5’ UTR, ORF 1ab gene, S gene, ORF 3a gene, E gene, M gene, ORF 6 gene, ORF 7a gene, ORF 7b gene, ORF 8 gene, N gene, ORF 10 gene and 3’ UTR. It has been reported about the discovery of a new variant namely B.1.1.7 (20I/501Y.V1), B.1.351 (20H/501Y.V2), B.1.429 (452R.V1), P.1-lineage (20J/501Y.V3). Consequently, the presence of the new variant of SARS-CoV-2 described above affects the risk of infection in immunized individuals.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalVirology & Mycology
  • SubjectInfectious Diseases
  • SubjectMicrobiology
  • BylineArticles whose byline prints “Edy Parwanto”